George Soros Biomarin Pharmaceutical Inc Transaction History
Soros Fund Management LLC
- $4.07 Billion
- Q2 2024
A detailed history of George Soros (Soros Fund Management LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Soros Fund Management LLC holds 156,053 shares of BMRN stock, worth $10.3 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
156,053
Previous 155,900
0.1%
Holding current value
$10.3 Million
Previous $13.6 Million
5.65%
% of portfolio
0.32%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
621Shares Held
183MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.5 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.26 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.24 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$922 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$641 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...